Nephros: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Nephros (NASDAQ:NEPH) reported Q4 earnings with an EPS of $-0.06, missing estimates by -200% against an expected $-0.02. Revenue increased by $742 thousand from the same period last year. Despite beating EPS estimates in Q3 2023, the share price dropped by 3.0% the following day. Historical earnings show mixed performance in terms of meeting EPS and revenue estimates.
March 07, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nephros reported a significant miss in Q4 earnings with an EPS of -$0.06, far below the estimated -$0.02, but showed an increase in revenue compared to last year.
The significant miss in EPS expectations is likely to negatively impact investor sentiment and could lead to a short-term decrease in NEPH's stock price, similar to the 3.0% drop observed after last quarter's earnings beat. The increase in revenue may provide some offset, but the missed EPS is a critical factor.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100